2 completed, 2 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Terminated 2 |
Follow ConjuChem: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy CJC-1134-PC Injection, Weekly placebo for CJC-1134-PC Injection - Type 2 Diabetes Mellitus (T2DM) | Phase 2 | Terminated | ConjuChem | 73 | 2011-09-01 | 2017-07-19 |
| A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Who Are Currently on Metformin Monotherapy 1.5 mg or 2.0 mg CJC-1134-PC, Placebo - Type 2 Diabetes Mellitus | Phase 2 | Completed | ConjuChem | 90 | 2008-03-01 | 2017-06-02 |
| A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Mellitus Who Are Currently on Metformin Monotherapy CJC-1134-PC, Placebo - Type 2 Diabetes Mellitus | Phase 2 | Completed | ConjuChem | 122 | 2008-02-01 | 2017-06-02 |
| A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity CJC 1295 - Obesity, HIV Infections | Phase 2 | Terminated | ConjuChem | 120 | 2005-12-01 | 2006-10-16 |
Diabetes Mellitus, Type 2 (3) · Diabetes Mellitus (1) · HIV Infections (1) · Obesity (1)
Canada (3) · United States (1)
Maggie Wang, MD (1) · Patrick Soon-Shiong, MD (1) · Robert Henry, MD (1)